Chen, S.L. et al. 2025. Efficacy and Safety of Orelabrutinib for Previously Treated Marginal Zone Lymphoma. Journal of Hematology. 14, 6 (Jan. 2025), 297–306. DOI:https://doi.org/10.14740/jh2149.